Effect of Alirocumab on Mortality After Acute Coronary Syndromes

Steg Philippe Gabriel, Szarek Michael, Bhatt Deepak L, Bittner Vera A, Brégeault Marie-France, Kollaborációs szervezet: ODYSSEY OUTCOMES Committees and Investigators, Merkely Béla Péter, Ungi Imre, Horváth Iván
2019

Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

Szarek Michael, Steg Ph Gabriel, DiCenso Dina, Bhatt Deepak L, Bittner Vera A, Kollaborációs szervezet: ODYSSEY OUTCOMES Committees and Investigators, Merkely Béla Péter, Ungi Imre, Horváth Iván
2019

Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial /

Jukema J. Wouter, Szarek Michael, Zijlstra Laurien E., de Silva H. Asita, Bhatt Deepak L., Kollaborációs szervezet: ODYSSEY OUTCOMES Committees and Investigators, Merkely Béla Péter, Ungi Imre, Horváth Iván
2019

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes a prespecified analysis of the ODYSSEY OUTCOMES ra...

Ray Kausik K., Colhoun Helen M., Szarek Michael, Baccara-Dinet Marie, Bhatt Deepak L., Bittner Vera A., Budaj Andrzej, Diaz Rene, Goodman Shaun G., Hanotin Corinne, Harrington Robert A., ODYSSEY OUTCOMES Committees and Investigators, Merkely Béla Péter, Ungi Imre, Katona András
2019

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Schwartz Gregory G., Steg P. Gabriel, Szarek Michael, Bhatt Deepak L., Bittner Vera A., Diaz R., Edelberg J.M, Goodman S.G, Hanotin C., Harrington R.A, Kollaborációs szervezet: ODYSSEY OUTCOMES Committees and Investigators, Merkely Béla Péter, Ungi Imre, Horváth Iván, et al
2018